Vertex Pharma Reports Update to US Prescribing Info for INCIVEK
December 19, 2012 at 08:34 AM EST
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX ) today announced that the INCIVEK® (telaprevir) label in the United States has been updated to include a Boxed Warning stating that fatal and non-fatal serious skin reactions have been reported in patients taking INCIVEK combination treatment. Fatal cases of serious skin reactions have